The biochemical basis for increased Testosterone production in theca cells propagated from patients with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 12, 2001, Pages 5925-5933

  Nelson, V L ^a   Qin, K N ^a   Rosenfield, R L ^a   Wood, J R ^a   Penning, T M ^a   Legro, R S ^a   Strauss III, J F ^a   McAllister, J M ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ENZYME PRECURSOR; FORSKOLIN; MESSENGER RNA; OXIDOREDUCTASE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBUNIT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; NORTHERN BLOTTING; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTOSTERONE RELEASE; TESTOSTERONE SYNTHESIS; THECA CELL;

FALLOPIA;

EID: 0035217099     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.12.8088     Document Type: Article

References (39)

1. The genetic basis of polycystic ovary syndrome
2. Polycystic ovarian disease
3. The polycystic ovary syndrome
4. The polycystic ovary syndrome
5. The polycystic ovary. Clinical and histologic features
6. The ovarian androgen producing ceils: A review of structure/function relationships
7. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
8. Role of 17β-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues
9. A guide to 17β-hydroxysteroid dehydrogenases
10. Compartmentalization of type I 17β-hydroxysteroid oxidoreductase in the human ovary
11. Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3
12. The molecular biology of androgenic 17β-hydroxysteroid dehydrogenases
13. Human ovarian expression of 17β-hydroxysteroid dehydrogenase types 1, 2, and 3
14. Molecular cloning of a novel widely expressed human 80 kDa 17β-hydroxysteroid dehydrogenase IV
15. Expression of 17β-hydroxysteroid dehydrogenase type 5 in human ovary: A pilot study
16. Immunocytochemical localization of type 5 17β-hydroxysteroid dehydrogenase in human reproductive tissues
17. Type 5 17β-hydroxysteroid dehydrogenase: Its role in the formation of androgens in women
18. 5-androstenediol as androgen prehormones in hirsute women
19. Studies of the nature of 17hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism
20. Human ovarian 17β-hydroxysteroid oxidoreductase activity: A comparison of normal and polycystic ovarian tissues
21. Human ovarian 17-ketosteroid oxidoreductase: Unique characteristics of the granulosa-luteal cell and stromal enzyme
22. Studies of testosterone metabolism in a patient with masculinization due to stromal hyperthecosis
23. Augmented androgen production is a stable phenotype of propagated theca cells from polycystic ovaries
24. Differential activity of the cytochrome P450 17α-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells
25. Expression and characterization of recombinant type 2 3α-hydroxysteroid dehydrogenase (HSD) from human prostate: Demonstration of bifunctional 3α/17β-HSD activity and cellular distribution
26. Structure-function aspects and inhibitor design of type 5 17β-hydroxysteroid dehydrogenase (AKRIC3)
27. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: Functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones
28. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
29. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach
30. Human theca intema cells in culture
31. Conditions for functional, long-term human theca interna and granulosa cell cultures from polycystic ovaries
32. Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3α-hydroxysteroid dehydrogenases
33. Enzymatic activities of P450c17 stably expressed in fibroblasts from patients with the polycystic ovary syndrome
34. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome
35. Detection of functional ovarian hyperandrogenism in women with androgen excess
36. Decreases in ovarian cytochrome P450C17 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome
37. Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome
38. Ovarian and adrenal function in polycystic ovary syndrome
39. The molecular basis of premature adrenarche: An hypothesis